Checking mixed reality mobility tests in adults with overweight or obesity
Compares mixed reality mobility tests with standard clinical tests in adults with obesity.
Plain-language title generated from the registry record
Registry title: Validity and Reliability of Mixed Reality-Based Performance Tests in Overweight and Obese Adults
Key facts
- Where
- Konya, TürkiyeSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 65 who are overweight or have obesity. It tests mixed reality performance tests against standard clinical tests.
- Age
- 18 to 65 years
- Sex
- All sexes can join.
- Disease stage
- Body Mass Index (BMI) of 25 kg/m² or more (overweight or obesity).
- Earlier treatment
- People who use anti-obesity medication cannot join.
Main reasons for not taking part
- Use of anti-obesity medication
- Pregnancy
- Chronic kidney disease or liver failure
- Recent major cardiovascular event, unstable angina, or heart failure NYHA Class III-IV
- Other conditions that may limit safe performance of the tests, such as respiratory failure, cardiac arrhythmias, cancer, or neurological or musculoskeletal disorders
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07654439, who can take part
Where in Türkiye
- Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and RehabilitationKonya, TürkiyeContact: Mehmet K ALTUNOK, PHD(c) in PTTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Selcuk University
- Trial code
- NCT07654439
- Record updated
- 17 June 2026
- Original description
This study aims to evaluate the validity and reliability of mixed reality (MR)-based adaptations of functional mobility and performance tests developed using the Meta Quest 3 platform by comparing their outcomes with conventional clinical assessments. Virtual and mixed reality technologies have gained increasing attention in clinical measurement due to their potential advantages, including assessment standardization, enhanced user interaction, and automated data collection.Read full original descriptionShow less
Validity and Reliability of the Mixed Reality Adaptation of Performance Tests in Overweight and Obese Individuals
This study aims to evaluate the validity and reliability of mixed reality (MR)-based adaptations of functional mobility and performance tests developed using the Meta Quest 3 platform by comparing their outcomes with conventional clinical assessments. Virtual and mixed reality technologies have gained increasing attention in clinical measurement due to their potential advantages, including assessment standardization, enhanced user interaction, and automated data collection.
Previous studies have demonstrated that virtual reality-based performance assessments can provide high reliability and show meaningful associations with traditional clinical measures across different populations. However, visual and vestibular stimuli, depth perception, and changes in movement strategies may cause performance in virtual environments to differ from performance in conventional settings. Therefore, the validity and reliability of each virtual or mixed reality adaptation should be established within the target population.
Overweight and obese individuals exhibit biomechanical and physiological characteristics that may affect balance, gait mechanics, joint loading, and physical performance. Consequently, measurement properties established in other populations cannot be assumed to apply directly to overweight and obese individuals. In addition, factors related to head-mounted displays and motion-tracking systems may influence assessment outcomes.
The purpose of this study is to evaluate the concurrent validity and test-retest reliability of mixed reality-based performance tests developed using the Meta Quest 3 platform. Measurement error parameters will also be determined to assess the clinical applicability of these MR-based assessments.
The findings of this study are expected to contribute to the development of safe, standardized, digital, and potentially remote assessment approaches for evaluating functional performance in overweight and obese individuals. Furthermore, the results may strengthen the scientific evidence supporting the use of digital assessment technologies in clinical practice.
Inclusion: Body Mass Index (BMI) ≥ 25 kg/m² (overweight or obesity),; Ability to ambulate independently,; Aged between 18 and 65 years,; Willingness to participate voluntarily in the study and provide written informed consent.
Exclusion: Use of anti-obesity medication,; Latent autoimmune diabetes in adults (LADA),; Chronic kidney disease,; Active or severe infections,; Liver failure,; Unstable angina,; Heart failure classified as New York Heart Association (NYHA) Class III-IV,; Respiratory failure, cardiac arrhythmias, neoplastic diseases, or neurological or musculoskeletal disorders that may limit the safe performance of the tests; Pregnancy,; Recent major cardiovascular events,.